1. P215 Blood-based prognostic biomarkers in Crohn's patients treated with biologics: a new promising tool to predict endoscopic outcomes. (27th May 2021) Authors: Grova, M; Crispino, F; Maida, M; Renna, S; Mocciaro, F; Casà, A; Rizzuto, G; Scimeca, D; Di Mitri, R; Macaluso, F S; Orlando, A Journal: Journal of Crohn's and colitis Issue: Volume 15(2021)Supplement 1 Page Start: S272 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. P255 Efficacy and safety of a restrictive ferric carboxymaltose infusion strategy for iron deficiency anemia in inflammatory bowel disease patients. (27th May 2021) Authors: Crispino, F; Grova, M; Maida, M; Renna, S; Casà, A; Rizzo, G; Macaluso, F S; Orlando, A Journal: Journal of Crohn's and colitis Issue: Volume 15(2021)Supplement 1 Page Start: S292 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. P288 Vedolizumab May Be An Effective Option For The Management Of Postoperative Recurrence Of Crohn's Disease. (27th May 2021) Authors: Macaluso, F S; Cappello, M; Crispino, F; Grova, M; Privitera, A C; Piccillo, G; Magnano, A; Ferracane, C; Belluardo, N; Giangreco, E; Fries, W; Viola, A; Di Mitri, R; Mocciaro, F; Camilleri, S; Garufi, S; Renna, S; Casà, A; Maida, M; Orlando, A Journal: Journal of Crohn's and colitis Issue: Volume 15(2021)Supplement 1 Page Start: S320 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. P345 The Effectiveness of Ustekinumab and Vedolizumab as Third-line Therapy in Patients with Refractory Crohn's Disease. (21st January 2022) Authors: Macaluso, F S; Grova, M; Saladino, M; Demarzo, M G; Privitera, A C; Giangreco, E; Garufi, S; Renna, S; Casà, A; Ventimiglia, M; Cappello, M; Fries, W; Orlando, A Journal: Journal of Crohn's and colitis Issue: Volume 16(2022)Supplement 1 Page Start: i359 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. P347 Sarcopenia is a poor prognostic factor for endoscopic outcomes in patients with Crohn's disease. (21st January 2022) Authors: Grova, M; Crispino, F; Maida, M; Vitello, A; Tesè, L; Rizzuto, G; Casà, A; Renna, S; Macaluso, F S; Orlando, A Journal: Journal of Crohn's and colitis Issue: Volume 16(2022)Supplement 1 Page Start: i360 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. P396 Ustekinumab Is A Promising Option For The Treatment Of Postoperative Recurrence Of Crohn's Disease. (30th January 2023) Authors: Macaluso, F S; Grova, M; Mocciaro, F; Di Mitri, R; Privitera, A C; Distefano, M E; Vitello, A; Camilleri, S; Ferracane, C; Pluchino, D; Belluardo, N; Giangreco, E; Fries, W; Viola, A; Cappello, M; Amato, L; Bertolami, C; Ventimiglia, M; Renna, S; Casà, A Journal: Journal of Crohn's and colitis Issue: Volume 17(2023)Supplement 1 Page Start: i528 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. P570 Safety and Effectiveness of Tofacitinib in Ulcerative Colitis: Real-world Data from TOFA-UC, a SN-IBD Study. (30th January 2023) Authors: Macaluso, F S; D'Antonio, E; Fries, W; Viola, A; Ksissa, O; Cappello, M; Muscarella, S; Belluardo, N; Giangreco, E; Mocciaro, F; Di Mitri, R; Ferracane, C; Vitello, A; Grova, M; Renna, S; Casà, A; Ventimiglia, M; Orlando, A Journal: Journal of Crohn's and colitis Issue: Volume 17(2023)Supplement 1 Page Start: i697 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. P613 Comparative objective effectiveness of vedolizumab and ustekinumab in a real-life cohort of active Crohn's disease patients failure to TNF inhibitors. (21st January 2022) Authors: Onali, S; Pugliese, D; Caprioli, F A; Orlando, A; Biancone, L; Nardone, O M; Imperatore, N; Fiorino, G; Cappello, M; Viola, A; Principi, M B; Bezzio, C; Aratari, A; Carparelli, S; Mazzuoli, S; Manguso, F; Grossi, L; Bodini, G; Ribaldone, D; Mocci, G Journal: Journal of Crohn's and colitis Issue: Volume 16(2022)Supplement 1 Page Start: i542 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. P703 The real-world long-term effectiveness of vedolizumab in inflammatory bowel diseases: a single-centre observational study. (25th January 2019) Authors: Macaluso, F S; Croce, A; Orlando, R; Ventimiglia, M; Sapienza, C; Gambino, F; Orlando, E; Grova, M; Rizzuto, G; Renna, S; Cottone, M; Orlando, A Journal: Journal of Crohn's and colitis Issue: Volume 13(2019)Supplement 1 Page Start: S472 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗